415 related articles for article (PubMed ID: 6606672)
1. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
2. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
4. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity.
Okamura J; Letarte M; Stein LD; Sigal NH; Gelfand EW
J Immunol; 1982 May; 128(5):2276-80. PubMed ID: 6460820
[TBL] [Abstract][Full Text] [Related]
5. A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.
Roth P; Halper JP; Weinstein IB; Pernis B
J Immunol; 1982 Aug; 129(2):539-44. PubMed ID: 6979576
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
7. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
8. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
9. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
Gazitt Y; Gangavalli A; Thurman GB
Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
Gazitt Y; Polliack A
Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic modulation of chronic lymphocytic, prolymphocytic, and lymphoplasmacytic leukemia cells by TPA: induction of TRAP isoenzyme 5 and HD6 (CD22) antigen and enhancement of IgM messenger RNA.
Thiel E; Pachmann K; Dörken B; Gaedicke G; Ziegler-Heitbrock HW
Blood Cells; 1987; 12(2):365-83. PubMed ID: 3476168
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester enhances both interleukin 2 receptor expression and immunoglobulin secretion in human Epstein-Barr virus-immortalized B cells.
Polke CR; Lowenthal JW; Roth SA; Rohwer P; MacDonald HR; Kalden JR
Eur J Immunol; 1986 Feb; 16(2):146-50. PubMed ID: 3007165
[TBL] [Abstract][Full Text] [Related]
14. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
15. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
Miller RA; Gralow J
J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
[TBL] [Abstract][Full Text] [Related]
16. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
[TBL] [Abstract][Full Text] [Related]
17. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
Okamura J; Gelfand EW; Letarte M
Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
[TBL] [Abstract][Full Text] [Related]
18. Induction of human B cell proliferation and differentiation by the combination of phorbol ester and ionomycin.
Roifman CM; Benedict SH; Cheung RK; Gelfand EW
Eur J Immunol; 1987 May; 17(5):701-6. PubMed ID: 3495445
[TBL] [Abstract][Full Text] [Related]
19. Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells.
Greene WC; Robb RJ; Depper JM; Leonard WJ; Drogula C; Svetlik PB; Wong-Staal F; Gallo RC; Waldmann TA
J Immunol; 1984 Aug; 133(2):1042-7. PubMed ID: 6330200
[TBL] [Abstract][Full Text] [Related]
20. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
Kadin ME; Nasu K; Sako D; Su IJ
Cancer Res; 1984 Aug; 44(8):3383-7. PubMed ID: 6611200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]